STAT+: The EPIC investigation, and a Teladoc surprise
Reported by STAT News · all stories from statnews.com
Editorial digest
Recent industry reporting highlights an inquiry concerning electronic health records leader Epic alongside unexpected developments at Teladoc. The piece addresses shifting commercial and operational dynamics across major health technology vendors.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom10/28/2026
STAT+: As Epic’s dominance grows, its iron grip is choking innovation in health technology
Epic Systems' expanding market influence is reportedly stifling technological innovation across the healthcare sector.
- Trusted health newsroom10/28/2026
Have you been impacted by Epic’s actions?
A news outlet is gathering first-hand experiences regarding the operational practices of health IT giant Epic.
- Trusted health newsroom10/30/2026
STAT+: FDA, CMS scramble to avoid regulatory logjam as more states look to test AI in clinical settings
Federal health agencies are working quickly to prevent oversight bottlenecks as states prepare clinical artificial intelligence trials.
- Trusted health newsroom10/26/2026
STAT+: HHS relaxes security, transparency rules for health record software used by hospitals
Federal health officials have eased transparency and data protection mandates for hospital electronic record platforms.
- Trusted health newsroom10/22/2026
STAT+: FDA finalizes its guidance on apps related to drugs, pharma rejoices
Federal regulators have completed formal guidelines for software applications paired with medications, drawing positive reactions from pharmaceutical manufacturers.
- Trusted health newsroom10/22/2026
STAT+: Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction
Virtual clinics are providing off-label GLP-1 therapies for substance use disorders before receiving formal regulatory authorization.